Mylan launches generic Zyvox

PITTSBURGH — Mylan on Tuesday announced it is launching linezolid tablets, the generic version of Pfizer's Zyvox.

Mylan received Food and Drug Administration approval to launch linezolid tablets in the 600 mg strength to treat certain infections caused by susceptible Gram-positive bacteria in adults and children.

Linezolid tablets, 600 mg, had U.S. sales of approximately $457.8 million for the 12 months ended Sept. 30, according to IMS Health.